Could You Live Better with OAB?

SOURCES:

U.S. National Library of Medicine: “Darifenacin,” “Mirabegron,” “Tolterodine,” “Oxybutynin Transdermal Patch,” “Oxybutynin Topical,” “Solifenacin,” “Trospium,”

National Institutes of Health: “Fesoterodine.”

Medscape: “Overactive Bladder Treatment & Management,” “Overactive Bladder Medication.”

Mayo Clinic: “Overactive Bladder,” “Oxybutynin (Oral Route).”

Urology Care Foundation: “What is Overactive Bladder?”

Wake Forest Baptist Health: “A Guide to Managing Overactive Bladder.”

American Family Physician: “AUA Releases Guideline on Diagnosis and Treatment of Overactive Bladder.”

Cleveland Clinic: “Are Your Medications Causing or Increasing Incontinence?”

The Cystitis & Overactive Bladder Foundation: “OAB Diet.”

Bladder & Bowel Community: “10 Overactive Bladder Treatment Options To Try.”

Columbus Regional Healthcare System: “Bladder Matters: A Guide to Managing Overactive Bladder.”

Reviews in Urology: “Smoking: Its Impact on Urologic Health.”

National Institute on Aging: “Urinary Incontinence in Older Adults.”

American Urological Association: “Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults (2019).”

University of Colorado: “Try PTNS for Overactive Bladder.”